1. Home
  2. TECX vs SRDX Comparison

TECX vs SRDX Comparison

Compare TECX & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • SRDX
  • Stock Information
  • Founded
  • TECX 2019
  • SRDX 1979
  • Country
  • TECX United States
  • SRDX United States
  • Employees
  • TECX N/A
  • SRDX N/A
  • Industry
  • TECX
  • SRDX Medical/Dental Instruments
  • Sector
  • TECX
  • SRDX Health Care
  • Exchange
  • TECX Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • TECX 334.4M
  • SRDX 415.4M
  • IPO Year
  • TECX 2018
  • SRDX 1998
  • Fundamental
  • Price
  • TECX $19.91
  • SRDX $28.52
  • Analyst Decision
  • TECX Buy
  • SRDX Buy
  • Analyst Count
  • TECX 6
  • SRDX 2
  • Target Price
  • TECX $78.67
  • SRDX $43.00
  • AVG Volume (30 Days)
  • TECX 244.3K
  • SRDX 74.5K
  • Earning Date
  • TECX 08-13-2025
  • SRDX 07-30-2025
  • Dividend Yield
  • TECX N/A
  • SRDX N/A
  • EPS Growth
  • TECX N/A
  • SRDX N/A
  • EPS
  • TECX N/A
  • SRDX N/A
  • Revenue
  • TECX N/A
  • SRDX $121,575,000.00
  • Revenue This Year
  • TECX N/A
  • SRDX N/A
  • Revenue Next Year
  • TECX N/A
  • SRDX $3.70
  • P/E Ratio
  • TECX N/A
  • SRDX N/A
  • Revenue Growth
  • TECX N/A
  • SRDX N/A
  • 52 Week Low
  • TECX $13.70
  • SRDX $26.00
  • 52 Week High
  • TECX $61.07
  • SRDX $42.44
  • Technical
  • Relative Strength Index (RSI)
  • TECX 43.97
  • SRDX 50.19
  • Support Level
  • TECX $17.97
  • SRDX $28.55
  • Resistance Level
  • TECX $20.75
  • SRDX $29.41
  • Average True Range (ATR)
  • TECX 1.40
  • SRDX 0.64
  • MACD
  • TECX -0.36
  • SRDX -0.06
  • Stochastic Oscillator
  • TECX 26.93
  • SRDX 39.13

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: